Skip to main content
. Author manuscript; available in PMC: 2014 Dec 12.
Published in final edited form as: Lung Cancer. 2013 Apr 21;81(1):47–52. doi: 10.1016/j.lungcan.2013.03.018

Table 3.

E1594: Median Overall Survival According to Histology and Chemotherapy Regimens

Regimens Histology
Squamous Cell
Carcinoma
n = 224		 Adenocarcinoma
n = 647		 Large Cell
Carcinoma
n = 74		 Others/Not
Otherwise
Specified
n = 194
Cisplatin-Paclitaxel - mo (95% CI) 6.9 (5.3-9.4) 9.1 (7.9-10.9) 6.1 (2.9-∞) 6.0 (3.9-9.1)
Cisplatin-Gemcitabine - mo (95% CI) 9.4 (5.7-15.6) 8.1 (6.8-9.8) 9.7 (4.5-17.1) 7.9 (6.3-11.3)
Cisplatin-Docetaxel - mo (95% CI) 8.1 (5.5-11.2) 7.7 (6.5-9.4) 6.8 (5.9-11.7) 8.2 (5.6-12.4)
Carboplatin-Paclitaxel - mo (95% CI) 9.3 (7.3-12.1) 7.6 (6.6-9.8) 8.3 (3.6-16.7) 6.9 (4.9-11.6)

CI, confidence interval